Publications

Intravesical hyaluronic acid instillation in treating recurrent cystitits in women long term results

The study focuses on evaluating the effectiveness of intravesical administration of hyaluronic acid (INSTYLAN) in reducing the frequency of recurrent urinary tract infections (UTIs) and improving symptoms in women. HA helps restore the protective urothelial barrier, reducing bacterial adhesion and inflammation. The study included 24 female patients who received INSTYLAN and 20 women in the control group (fosfomycin). The results showed a significant reduction in the frequency of UTIs in the INSTYLAN group, no serious side effects, and improved patient satisfaction.

(more…)

Intravesical hyaluronic acid instillation in treating recurrent cystitis in women: preliminar observation

Intravesical instillation of hyaluronic acid repairs the GAG layer on the urothelial surface and prevents therefore bacterial adhesion. EAU Guidelines show that endovesical instillations of hyaluronic acid and chondroitin sulphate have been used for glycosaminoglycan (GAG) layer replenishment in the treatment of interstitial cystitis, overactive bladder, radiation cystitis, and for prevention of rUTI.

(more…)

SAFETY AND EFFICACY OF INTRAVESICAL ADMINISTRATION FOR SYMPTOM CONTROL IN CHRONIC CYSTOPATHY

INTRODUCTION: Chronic cystopathy is a widespread pathology. Intravesical hyaluronic acid (instillation) is one of the treatment options for cystopathies. This study analyzed safety and efficacy of intravesical hyaluronic acid instillations in patients with symptoms of urinary blabber disease.

(more…)

Intravesical instillations of high molecular weight sodium hyaluronate in radiation cystitis

Intravesical instillation of high molecular weight sodium hyaluronate in radiation‑induced cystitis: a prospective pilot study

Purpose. To assess the efficacy and safety of intravesical instillation of high molecular weight sodium hyaluronate (HMW- HA) for the treatment of radiation-induced cystitis.

(more…)

SELF-MEDICATION CAN BE HARMFUL TO YOUR HEALTH

Before using the product offered on this information resource, it is recommended to consult your doctor and read the instructions.

Information about medical products for the professional work of health professionals. INSTYLAN (INSTILAN) 0.16% colorless, transparent, viscous gel of hyaluronic acid of non-animal origin, sterile, physiological pH.

INSTYLAN 0,16% approved as Class ІІa medical devices. EU Declaration of Conformity. Registration number: DD 60107286 0001 Manufacturer: Diaco Biofarmaceutici S.R.L. Via Flavia 124, 34147, Trieste, Italy. E-mail: info@diaco.it. www.diaco.it.

Search

Publications

Intravesical hyaluronic acid instillation in treating recurrent cystitits in women long term results

Intravesical hyaluronic acid instillation in treating recurrent cystitis in women: preliminar observation

SAFETY AND EFFICACY OF INTRAVESICAL ADMINISTRATION FOR SYMPTOM CONTROL IN CHRONIC CYSTOPATHY

Intravesical instillation of high molecular weight sodium hyaluronate in radiation‑induced cystitis: a prospective pilot study

[:en]Subscribe2[:it]Subscribe2[:es]Subscribe2[:ua]Subscribe2[:fr]Subscribe2[:]